Smith & Nephew (SN.)

Sector:

Health Care

Index:

FTSE 100

961.00p
   
  • Change Today:
      9.60p
  • 52 Week High: 1,208.50
  • 52 Week Low: 917.60
  • Currency: UK Pounds
  • Shares Issued: 874.38m
  • Volume: 2,394,380
  • Market Cap: £8,403m
  • RiskGrade: 173
  • Beta: 0.64

Smith and Nephew Overview

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. It is focused on the repair, regeneration and replacement of soft and hard tissue. It operates through three segments: Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that helps surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Smith and Nephew Financials

Latest F'cast
Div Yield 3.1% 0.0%
Div Cover 2.2 2.4
Op Mrgn 7.7% 15.7%
ROCE 9.1%  
Latest F'cast
P/E 14.6 13.7
PEG 11.9 n/a
Pr/Revenue 1.9 1.4
Pr/Book 2.0  
Latest F'cast
Revenue 6.4% -17.9%
PBT 23.4% 147.0%
EPS 1.2% -16.3%
DPS n/a -40.0%

Smith and Nephew Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 5,138.00 743.00 102.20¢ 22.8 22.8 +1% 37.50¢ 1.6%
31-Dec-20 4,560.00 246.00 64.60¢ 29.7 n/a -37% 37.50¢ 2.0%
31-Dec-21 5,212.00 586.00 80.90¢ 20.3 0.8 +25% 37.50¢ 2.3%
31-Dec-22 5,215.00 235.00 81.80¢ 17.2 17.2 +1% 37.50¢ 2.7%
31-Dec-23 5,549.00 290.00 82.80¢ 16.5 16.5 +1% 37.50¢ 2.7%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Smith and Nephew Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 5,784.07 909.75 69.32p 13.9 n/a -16% 28.59p 0.0%
31-Dec-25 6,075.24 1,060.28 81.79p 11.7 0.7 +18% 31.80p 0.0%
31-Dec-26 6,388.43 1,166.32 92.54p 10.4 0.8 +13% 35.10p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Smith and Nephew Company Announcements

Director/PDMR Shareholding 12-Nov-2024 07:00 RNS
Director/PDMR Shareholding 11-Nov-2024 16:45 RNS
Director/PDMR Shareholding 01-Nov-2024 15:44 RNS

Latest Smith and Nephew Director Deals

Traded Action Notifier PriceAmountValue
11-Nov-24 Buy Rupert Soames 935.90p 5,344 £50,014.50
23-Sep-24 Buy Marc Owen 2,310.85p 174 £4,020.87
16-Sep-24 Buy Simon Lowth 1,189.93p 300 £3,569.78

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Smith and Nephew Market Data

Currency UK Pounds
Share Price 961.00p
Change Today 9.60p
% Change 1.01 %
52 Week High 1,208.50
52 Week Low 917.60
Volume 2,394,380
Shares Issued 874.38m
Market Cap £8,403m
Beta 0.64
RiskGrade 173

Smith and Nephew Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
77.35% below the market average77.35% below the market average77.35% below the market average77.35% below the market average77.35% below the market average
65.71% above the sector average65.71% above the sector average65.71% above the sector average65.71% above the sector average65.71% above the sector average
Price Trend
22.19% below the market average22.19% below the market average22.19% below the market average22.19% below the market average22.19% below the market average
8.11% above the sector average8.11% above the sector average8.11% above the sector average8.11% above the sector average8.11% above the sector average
Income
1.62% below the market average1.62% below the market average1.62% below the market average1.62% below the market average1.62% below the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
35.36% below the market average35.36% below the market average35.36% below the market average35.36% below the market average35.36% below the market average
94.44% below the sector average94.44% below the sector average94.44% below the sector average94.44% below the sector average94.44% below the sector average

What The Brokers Say

Strong Buy 6
Buy 4
Neutral 6
Sell 0
Strong Sell 1
Total 17
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Smith and Nephew Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-24 28-Mar-24
Paid 08-Nov-24 22-May-24
Amount 14.40¢ 23.10¢

Trades for 14-Nov-2024

Time Volume / Share Price
16:47 2,064 @ 947.16p
16:35 92,783 @ 961.00p
16:35 33,538 @ 961.00p
16:35 1,273,843 @ 961.00p
16:35 3,834 @ 961.00p

Smith and Nephew Key Personnel

CEO Deepak Nath
CFO John Rogers

Top of Page